EAN 2017 | ASL MRI as an early biomarker for Alzheimer’s disease
M. Hale Alpsan Gökmen, MD from the Anadolu Health Center, Gebze, Turkey discusses a study on arterial spin labeling (ASL) MRI as an early biomarker for Alzheimer’s disease. Dr Gökmen emphasizes the importance of diagnosing patients early and summarizes the findings of their study.
Recorded at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands.
Get great new content delivered to your inboxSign up